Dataset
Clinical Trial Protocol: VAC060 Protocol v3.0
- Alternative title:
- VAC 060:A Phase Ib randomised, controlled, single-blind study to assess the safety, immunogenicity of the Malaria Vaccine Candidate R21 with Matrix-M1 adjuvant in West African adult volunteers.
- Documentation:
- This is a clinical trial protocol describing the VAC 060 study, undertaken by the Jenner Institute, sponsored by the University of Oxford. It was funded by a Strategic Primer grant award from the European and Developing Countries Clinical Trials Partnership (EDCTP) with co-funding from Swedish International Development Cooperation Agency (Sida); UK Medical Research Council; Irish Aid, Department of Foreign Affairs and Trade, Ireland;and Bundesministerium für Bildung und Forschung (BMBF), Germany and was performed by the Malaria Vectored Vaccines Consortium 2 (MVVC 2) (EDCTP, grant number SP.2011.41304.025). The European Vaccine Initiative (EVI) coordinated the EDCTP-funded MVVC 2 project. The work was also supported by the UK National Institute of Health Research through the Oxford Biomedical Research Centre (http://oxfordbrc.nihr.ac.uk/) (A91301 Adult Vaccine) and the Wellcome Trust (https://www. wellcome.ac.uk/) (084113/Z/07/Z).
Actions
Authors/Creators
- Publisher:
- University of Oxford
- Publication date:
- 2019
- DOI:
- UUID:
-
uuid:b8f96d59-8042-4271-a600-29545676f050
- Deposit date:
-
2019-07-15
Terms of use
- Copyright date:
- 2019
- Licence:
- ORA Terms and conditions
If you are the owner of this record, you can report an update to it here: Report update to this record